Ameritas Investment Company’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
FP
TP
Ameritas Investment Company's MRNA Position: Q3 2021 in Review
Ameritas Investment Company increased its Moderna (MRNA) stake by 228% in Q3 2021, buying an estimated $482K and bringing the position to 1,878 shares worth $723K. The position accounts for 0.03% of the portfolio, ranked #332.
Ameritas Investment Company first reported a position in MRNA in Q1 2020 and has held it in 4 quarters since. 1,141 funds tracked by Wall St. Rank hold MRNA as of Q3 2021.
- Ameritas Investment Company held 1,878 shares of Moderna worth $723K as of Q3 2021.
- Ameritas Investment Company bought 1,306 Moderna shares in Q3 2021, an estimated $482K.
- Moderna made up 0.03% of Ameritas Investment Company's portfolio in Q3 2021, its #332 holding.
- Ameritas Investment Company first reported a position in Moderna in Q1 2020 and has held it in 4 quarters since.
- 1,141 funds tracked by Wall St. Rank held Moderna as of Q3 2021.
Based on Ameritas Investment Company's 13F filing for Q3 2021, filed 12 Nov 2021.